Comparison of Pre- versus Post-Meal Administration of Miglitol for Plasma Glucagon-like Peptide-1 and Glucose-dependent Insulinotropic Polypeptide Levels

Comparison of Pre- versus Post-Meal Administration of Miglitol for Plasma Glucagon-like Peptide-1 and Glucose-dependent Insulinotropic Polypeptide Levels - Miglitol and incretin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002896

Enrollment

Registered

2009-12-18

Start date

2009-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

no miglitol drug administered just before a meal drug administered at 30 min after the start of a meal)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients and healthy volunteers

Exclusion criteria

Exclusion criteria: pregnacy

Design outcomes

Primary

Measure	Time frame
The difference of incretin secretion	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026